Artiva Biotherapeutics
Developing NK cell therapies
- B2B
About Artiva Biotherapeutics
Immunotherapy company producing allogeneic NK cell therapies at scale for autoimmune diseases and cancers, focusing on enhancing monoclonal antibody activity
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- san diego, california, United States
- Founded
- 2019
- Revenue
- $17M – $134MTamtam estimate
- Website
- artivabio.com
Artiva Biotherapeutics at a glance
Artiva Biotherapeutics is a B2B company in the Biotechnology Research industry, headquartered in san diego, california, United States.
Artiva Biotherapeutics was founded in 2019.
Artiva Biotherapeutics has 51–250 employees.
Artiva Biotherapeutics's revenue is $17M – $134M (Tamtam estimate).
Frequently asked questions about Artiva Biotherapeutics
What is Artiva Biotherapeutics's revenue?
Tamtam estimates Artiva Biotherapeutics's annual revenue at $17M – $134M.
How many employees does Artiva Biotherapeutics have?
Artiva Biotherapeutics has 51–250 employees.
Where is Artiva Biotherapeutics headquartered?
Artiva Biotherapeutics is headquartered in san diego, california, United States.
Selling to companies like Artiva Biotherapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies